MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission - ScienceDirect
Mitochondrial Trails in the Neurotoxic Mechanisms of MDMA - ScienceDirect
Frontiers | Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated | Psychiatry
Psychedelics and Hallucinogens in Psychiatry - Mechanisms of Action and Clinical Application
Figure 2 | Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview | SpringerLink
Psychoactive Drugs | BioNinja
MDMA - Wikipedia
A Schematic Representation of MDMA's Sites of Action in Frontal Cortex.... | Download Scientific Diagram
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. - Abstract - Europe PMC
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine | Journal of Neuroscience
Chapter 14: Psychedelics – Drugs and Behavior
Toxicology Section // MDMA at glance
PDF) The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Increased Anxiety 3 Months after Brief Exposure to MDMA ('Ecstasy') in Rats: Association with Altered 5-HT Transporter and Receptor Density | Neuropsychopharmacology
A) Chemical structures of MDA, MDMA, MDDMA, and MDTMA. (B) Heat map of... | Download Scientific Diagram
Aripiprazole Mechanism Action Stock Vector (Royalty Free) 298822301 | Shutterstock
The Neurobiology of Ecstasy (MDMA) | National Institute on Drug Abuse (NIDA)
Mitochondrial Trails in the Neurotoxic Mechanisms of MDMA - ScienceDirect
Pharmaceuticals | Free Full-Text | Methylenedioxymethamphetamine (MDMA, ' Ecstasy'): Neurodegeneration versus Neuromodulation | HTML
Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less “go” and more “stop” from the motor striatum for robust therapeutic effects | CNS
